Germany - medicaments

Description

Name: Non-ionic iodine-containing monomeric low osmolar water-soluble nephrotrope X-ray contrast medium.application: Intraarterial and intravenous and intracavitary. Other possible fields of application:- urography,- computer tomography,- angiography,- digital subtraction angiography (DSA),- angiocardiography, coronary arteriography, interventional coronary arteriography,- fistulography, galactography.Active substances/combinations (ATC): iohexol (V08AB02) and/or iopamidol (V08AB04) and/or iopromide (V08AB05) and/or iomeprole (V08AB10) and/or iobitridol (V08AB11) and/or ioversol (V08AB07) and/or other possible pharmaceutical forms: All approved dosage forms of an active substance must be offered. concentration: 400 mg/ml. package size: all approved package sizes of an active substance must be offered. further information can be found in Annex 11 to the invitation to tender. Name: Non ionic iodine-containing dimeric low osmolar water-soluble nephrotrope X-ray contrast medium: Intraarterial and intravenous. Other possible applications:- Cerebral angiography, abdominal angiography, peripheral arteriography, venography,- urography,- contrast enhancement in computed tomography (CT).Active ingredients/combinations (ATC): Iodixanol (V08AB09) and/or other possible.dosage forms: Concentrations must be offered cumulatively:1 270 mg/ml (all concentrations of an active substance must be offered)2 320 mg/ml (all concentrations of an active substance must be offered)2 320 mg/ml (all concentrations of an active substance must be offered) (all fields of application must be covered at least together).Package size: all approved package sizes of an active substance must be offered.Further information can be found in Annex 11 to the invitation to tender. Name: Paramagnetic extracellular linear contrast medium for MRI application: Intraarticular application. fields of application: Direct magnetic resonance arthrography.NSF Risk: high NSF Risk class.Active ingredients/combinations (ATC): gadopentetic acid (V08CA01).dosage forms: Concentration: 0,002 mmol/ ml.Package size: All package sizes of the active substance for this indication Further information can be found in Annex 11 to the invitation to tender. Name: Paramagnetic extracellular macrocyclic contrast agent for MRI application: Intraarticular application. fields of application: Direct Magnetic Resonance Arthrography.NSF Risk: Low NSF Risk Class.Active ingredients/combinations (ATC): Gadotic Acid (V08CA02).Dosage Forms: Concentration: 0,0025 mmol/ ml.Package size: All package sizes of the active substance for this indication Further information can be found in Annex 11 to the invitation to tender. Title: Paramagnetic extracellular linear contrast agent for MRI with renal excretion and partial biliary excretion: Intravenous. Other applications possible: MRI of the liver.NSF Risk: Medium NSF Risk class.Active ingredients/combinations (ATC): Gadobenoic acid (V08CA08).Dosage forms: All approved pharmaceutical forms of an active substance.concentration: all concentrations possible.package size: all approved package sizes of the active substance.further information can be found in Annex 11 to the invitation to tender. Name: Paramagnetic combines extracellular and hepatobiliary linear contrast media for MRI (excretion 50-50).application: Intravenous use. Other applications possible: NSF Risk: Mean NSF Risk Class.Active ingredients/combinations (ATC): Gadoxotic acid (V08CA10).Dosage forms: All dosage forms of the active substance.concentration: all concentrations possible.package size: all package sizes of the active substance.further information can be found in Annex 11 to the invitation to tender. Application: Oral and/or intestinal and/or rectal application. Fields of application: Representation of parts of the digestive tract and/or of the entire digestive tract by CT and/or X-ray, further active agents/combinations (ATC): barium sulphate (V08BA): All dosage forms of the active substance.Concentration: All concentrations possible.Package size: All package sizes of the active substance.Further information can be found in Annex 11 to the invitation to tender. Name: Ultrasound contrast medium Application: Intravenous application. areas of application: Echocardiography, other possible.Active substances/combinations (ATC): All active substances of the ATC Group V08DA possible.Dosage forms: All dosage forms of the active substance.Concentration: All concentrations possible.Package size: All package sizes of the active substance.Further information can be found in Annex 11 to the invitation to tender.

Opportunity closing date

28 February 2021

Value of contract

to be confirmed